Who are valproid acid plus corticosteroids's main competitors?

No direct comparators detected in our index.

How often does this brief refresh?

Every 30 minutes from primary sources (FDA, EMA, MHRA, PMDA, ClinicalTrials.gov, USPTO). Subscribe to the RSS feed below for push alerts.

How do I get this as a recurring report?

Subscribe to /feed/ci/valproid-acid-plus-corticosteroids.xml in any RSS reader (Feedly, Inoreader, NewsBlur). Every regulatory action, trial readout, or patent event lands in your feed automatically.

Last reviewed 2026-06-10 · How we verify

valproid acid plus corticosteroids — Competitive Intelligence Brief

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

valproid acid plus corticosteroids (valproid acid plus corticosteroids) competitive landscape: 0 comparators, recent regulatory actions, upcoming PDUFA, patent timeline. Class: Mood stabilizer, Anti-inflammatory. Area: Neurology, Immunology.

phase 3 Mood stabilizer, Anti-inflammatory Neurology, Immunology Small molecule Live · refreshed every 30 min

Target snapshot

valproid acid plus corticosteroids (valproid acid plus corticosteroids) — University of Sao Paulo. Valproic acid is a mood stabilizer that works by reducing the activity of certain brain chemicals, while corticosteroids are anti-inflammatory agents that reduce swelling and inflammation.

Comparator set

Auto-detected by same drug class / molecular target / therapeutic area, ranked by phase + recency. Override with ?vs=slug1,slug2,….

Drug	Generic	Sponsor	Phase	Class	Target	Approval / PDUFA
valproid acid plus corticosteroids TARGET	valproid acid plus corticosteroids	University of Sao Paulo	phase 3	Mood stabilizer, Anti-inflammatory

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this set.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this set.

Patent timeline (forward window)

No upcoming patent expiries for this set.

Sponsor landscape (Mood stabilizer, Anti-inflammatory class)

University of Sao Paulo · 1 drug in this class

Subscribe to ongoing alerts

Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:

Cite this brief

Drug Landscape (2026). valproid acid plus corticosteroids — Competitive Intelligence Brief. https://druglandscape.com/ci/valproid-acid-plus-corticosteroids. Accessed 2026-06-10.

Build your own brief

Pick any drug + add comparators:

https://druglandscape.com/ci/{slug} — auto-detected competitors
https://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3 — explicit comparators
Brand names auto-resolve: /ci/keytruda → 301 → /ci/pembrolizumab

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing